This phenomenon can be explained by the above findings that the high expression of CXCR4 is accompanied by the high expression of immune checkpoints, and patients are often inhibited in the body's anti-tumor immune activity, resulting in poor prognosis. This evidence concerns the gene CXCR4 and neoplasm.